SCHEMBL25839563

SCHEMBL25839563

COC(=O)c1cnn2c(N(Cc3ccccc3)Cc3ccccc3)c(Br)c(NCc3cc(F)cnc3O[C@@H](C)CNC(=O)OC(C)(C)C)nc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.34
▸ HPGD P15428 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ JAK2 O60674 1/20 0.32
▸ NTRK1 P04629 1/20 0.32
▸ RECQL P46063 1/20 0.31
▸ MKNK2 Q9HBH9 1/20 0.31
▸ TSHR P16473 2/20 0.31
▸ USP2 O75604 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ MAPK10 P53779 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30309824 1.00 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25839577 0.91 ALDH1A1 (0.35) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25118141 0.90 ALDH1A1 (0.33) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25839766 0.90 ALDH1A1 (0.33) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25839690 0.90 JAK2 (0.35) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25416742 0.89 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25839656 0.89 ALDH1A1 (0.33) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25171195 0.89 JAK3 (0.33) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25839652 0.88 ALDH1A1 (0.31) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL25118112 0.84 ALDH1A1 (0.39) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219978-A1 COMPOUND HAVING MACROCYCLIC STRUCTURE AND USE THEREOF SCINNOHUB PHARMACEUTICAL CO., LTD (CN) 2023-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219978-A1 COMPOUND HAVING MACROCYCLIC STRUCTURE AND USE THEREOF BTK, SRC, YES1 ALDH1A1 4689/4885HPGD 4855/4885KDM4E 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback